Symptom to treatment delay* | Hospital delay† | |||
---|---|---|---|---|
Median | 25–75% IQR | Median | 25–75% IQR | |
IQR = interquartile range. | ||||
*Time from onset of symptoms until start of treatment. | ||||
†Time from first visit to chest physician at the hospital until start of treatment (significant differences in delay if p<0.05). | ||||
‡Significant difference in hospital delay. | ||||
§Significant difference between patients with stage IV disease and those with stage I–II, IIIa and IIIb disease in a separate analysis for each group. | ||||
¶Significant difference in delay between patients with stage I–II and IIIB disease in both types of delay. | ||||
**Significant differences in both types of delay. | ||||
All patients | 4.6 | 3.0–7.1 | 1.6 | 0.9–2.4 |
Sex | ||||
Female | 4.6 | 3.2–6.8 | 1.5 | 1.0–2.6 |
Male | 4.7 | 2.8–7.1 | 1.5 | 0.9–2.2 |
Age‡ | ||||
⩽70 years | 4.7 | 2.5–6.9 | 1.5 | 0.9–2.1 |
>70 years | 4.5 | 3.2–7.6 | 1.8 | 1.2–2.7 |
Stage§,¶ | ||||
I–II | 5.5 | 3.8–8.0 | 1.9 | 1.4–2.9 |
IIIa | 5.1 | 3.1–7.7 | 1.8 | 1.1–3.0 |
IIIb | 4.6 | 3.0–7.4 | 1.5 | 0.9–2.3 |
IV | 3.4 | 2.0–4.8 | 1.2 | 0.7–2.0 |
Histopathological type | ||||
Squamous cell | 5.1 | 3.2–7.6 | 1.7 | 1.0–2.5 |
Adenocarcinoma | 4.3 | 2.8–6.6 | 1.5 | 0.9–2.2 |
Type of treatment** | ||||
Surgery | 5.3 | 3.7–6.9 | 1.8 | 1.3–2.7 |
Non-surgical | 4.2 | 2.6–7.1 | 1.4 | 0.8–2.3 |